| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.095 | 0.04 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.09 | 0.04 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.076 | 0.1 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.074 | 0.2 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.059 | 0.2 |